Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||21 January 2008|
|PDF File Size:||3.10 Mb|
|ePub File Size:||17.14 Mb|
|Price:||Free* [*Free Regsitration Required]|
Print Send to a friend Export reference Mendeley Statistics. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Subscriber If you already have your login data, please click here.
Are you a health professional able to prescribe or dispense drugs? This item has received.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. There were no plasmminogeno or embolism. In 4 patients complete resolution of the thrombus was achieved in a mean of 3. Nine issues are published each year, including mostly originals, reviews and consensus documents. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.
Continuing navigation will be considered as acceptance of this use. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. SNIP measures contextual citation impact by wighting citations based recombinatne the total number of citations acivador a subject field. You can change the settings or obtain more information by clicking here.
SRJ is a prestige metric recojbinante on the idea that not all citations are the same. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days. March Pages ee24 Pages CiteScore measures average citations received per document published. From Monday to Friday from 9 a. Subscribe to our Newsletter. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.
Thrombolysis with recombinant tissue plasminogen pkasminogeno rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization.
SJR uses tisulaar similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Previous article Next article. Si continua navegando, consideramos que acepta su uso.
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. The patients included 4 males with a mean weight of gr.
Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
There was a problem providing the content you requested
They received between 1 to 5 cycles with rTPA. Three patients received low molecular weight heparin prior to using rTPA. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.